메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Cho, Hee-Jeong (Department of Hematology/Oncology, Kyungpook National University Hospital) Seo, Sang-Kyung (Department of Hematology/Oncology, Kyungpook National University Hospital) Baek, Dong Won (Department of Hematology/Oncology, Kyungpook National University Hospital) Park, Sung-Woo (Department of Hematology/Oncology, Kyungpook National University Hospital) Lee, Yoo-Jin (Department of Hematology/Oncology, Kyungpook National University Hospital) Sohn, Sang-Kyun (Department of Hematology/Oncology, Kyungpook National University Hospital) Lee, Ho-Sup (Department of Hematology/Oncology, Kosin University Gospel Hospital) Lee, Won Sik (Department of Hematology-Oncology, Inje University Pusan Baik Hospital) Lee, Ji Hyun (Department of Hematology-Oncology, Dong-A University Hospital) Kim, Sung Hyun (Department of Hematology-Oncology, Dong-A University Hospital) Moon, Joon-Ho (Department of Hematology/Oncology, Kyungpook National University Hospital)
저널정보
영남대학교 의과대학 영남의대학술지 영남의대학술지 제35권 제1호
발행연도
2018.1
수록면
76 - 83 (8page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: Elderly patients with multiple myeloma (MM) are vulnerable to adverse events (AEs). This study evaluated adherence to chemotherapy and treatment outcomes in elderly patients treated with a frontline bortezomib (BTZ), melphalan, and prednisone (VMP) regimen and regimens without BTZ. Methods: One-hundred and forty elderly patients who were diagnosed with MM from March 2007 to March 2015 were included in this retrospective study. To evaluate regimen adherence, patients who were treated with more than 4 cycles were assigned to the good adherence group. Results: Among the 140 patients, 71 were treated with a frontline VMP and 69 with non-BTZ regimens. The median age was 71 years (range, 65-90 years). The VMP group showed a higher complete response rate than the non-BTZ group: 26.8% vs. 7.2%. More patients in the VMP group achieved ${\geq}$very good partial response (VGPR) and ${\geq}PR$. In the VMP group, 27 patients (38.0%) received less than 4 cycles. The VMP good adherence group showed a higher 3-year overall survival (OS) rate (70.9%) than the poor adherence group (60.2%, p=0.059). In the multivariate analysis, treatment with ${\geq}4$ cycles of VMP was a favorable factor for OS. Conclusion: A good adherence to a frontline VMP regimen resulted in favorable long-term survival. Adequate management of AEs will be needed to achieve favorable outcomes in elderly patients with MM.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0